Efficacy and tolerability of quinacrine monotherapy and albendazole plus chloroquine combination therapy in nitroimidazole-refractory giardiasis: a TropNet study
Clicks: 175
ID: 266652
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
175 views
33 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #301 of 1,084 articles by views in clinical infectious diseases
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 1,084 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
AbstractBackground. Giardiasis failing nitroimidazole first-line treatment is an emerging clinical problem in returning European travelers. We present data on t
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (20 words).
Try re-searching for a better abstract.
| Reference Key |
andreasclinicalefficacy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Neumayr, Andreas;Schunk, Mirjam;Theunissen, Caroline;Van Esbroeck, Marjan;Mechain, Matthieu;Hatz, Christoph;Mørch, Kristine;Soriano Pérez, Manuel Jesús;Sydow, Véronique;Sothmann, Peter;Kuenzli, Esther;Rothe, Camilla;Bottieau, Emmanuel;on behalf of TropNet; |
| Journal | clinical infectious diseases |
| Year | Year not found |
| DOI |
DOI not found
|
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.